SCHEMBL4440945

SCHEMBL4440945

COc1ccccc1CNC(=O)c1cccc2nc[nH]c12

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.63
ALDH1A1 P00352 5/20 0.58
KDM4E B2RXH2 3/20 0.58
RCE1 Q9Y256 1/20 0.58
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
PLA2G1B P04054 1/20 0.54
ATG4B Q9Y4P1 1/20 0.54
GAA P10253 2/20 0.53
PKM P14618 1/20 0.53
HTT P42858 1/20 0.53
NPC1 O15118 1/20 0.52
POLB P06746 2/20 0.51
HDAC1 Q13547 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
NLRP3 Q96P20 1/20 0.50
MAPT P10636 1/20 0.49
MAPK14 Q16539 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4235288 0.80 HPGD (0.62) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL4235282 0.78 HPGD (0.58) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL7369653 0.77 BRD4 (0.41) HPGDALDH1A1KDM4EKMT2AMEN1
SCHEMBL19747579 0.76 HPGD (0.78) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL12821388 0.75 HPGD (0.67) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL7651189 0.74 HPGD (1.00) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL22972357 0.73 HPGD (0.72) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL1201512 0.73 LMNA (0.49) HPGDALDH1A1KDM4ERCE1KMT2A
SCHEMBL536590 0.73 KDM4E (0.46) HPGDALDH1A1KDM4EKMT2AMEN1
SCHEMBL1477696 0.73 P2RX7 (0.45) ALDH1A1KDM4EKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125753-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed
WO-2008082003-A1 FUSED HETEROCYCLIC COMPOUNDS HAVING CRF ANTAGONISTIC ACTIVITY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-10 WO disclosed